Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06660381 · ClinicalTrials.gov registry record · Phase 1

Psilocybin-assisted Treatment for Cannabis Use Disorder

A Phase 1 study of Cannabis Use Disorder, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 1
Development phase
12
Enrollment target
1
Study location

NCT06660381 is a Phase 1 study of Cannabis Use Disorder that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 12 participants, below the 109-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06660381, a Phase 1 study of Cannabis Use Disorder, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 1
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

This pilot study will evaluate the therapeutic potential of psilocybin in people with Cannabis Use Disorder (CUD). This study will examine the impact of psilocybin treatment on cannabis use and related variables in 12 people with CUD. This is an open-label proof-of-concept trial in which participants will complete a 12-week course of study treatment including two psilocybin sessions with psychological support, and follow-up assessments 3 and 6 months after the first psilocybin session.

Conditions Studied

Cannabis Use Disorder

Interventions

  • DRUG Psilocybin

Study Locations (1)

Maryland

  • Johns Hopkins Center for Psychedelic and Consciousness Research - Baltimore

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-11-08
Est. Completion 2026-12
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06660381

The ClinicalTrials.gov registry entry for NCT06660381 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 34 other Cannabis Use Disorder trials with a reported enrollment target (89% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cannabis Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Psilocybin is the first listed.

NCT06660381 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT06660381 about?

NCT06660381 is a clinical study titled "Psilocybin-assisted Treatment for Cannabis Use Disorder". This pilot study will evaluate the therapeutic potential of psilocybin in people with Cannabis Use Disorder (CUD). This study will examine the impact of psilocybin treatment on cannabis use and related variables in 12 people with CUD. This is an open-label proof-of-concept trial in which participant...

What is the current status of trial NCT06660381?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2024-11-08. Estimated completion is 2026-12.

What conditions does trial NCT06660381 study?

This clinical trial studies the following conditions: Cannabis Use Disorder.

What interventions are being tested in trial NCT06660381?

The interventions under investigation include: Psilocybin (DRUG).

Who is sponsoring clinical trial NCT06660381?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06660381 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cannabis Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cannabis Use Disorder

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.